Kamada (NASDAQ:KMDA – Get Free Report) and Rhythm Pharmaceuticals (NASDAQ:RYTM – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two companies based ...

Motherhood is a beautifully rewarding and transformative journey. While parents often prepare for a child’s arrival — be it ...

Researchers say they found that infection with a common virus that can be transmitted from mother to fetus before birth ...

Researchers say they found that infection with a common virus that can be transmitted from mother to fetus before birth ...

CRISPR technology, driven by Cas9, redefines gene editing, facilitating targeted DNA modifications that advance genetic ...

There are a lot of empty words at these types of proceedings, but those were not. The Spyteks are co-founders of the National ...

Newborn testing has long-term heath outcomes, but legislative changes could affect newborn screening effectiveness.

Research by the ASU-Banner Neurodegenerative Research Center proposes that a common herpes virus may travel through the body ...

Ben Readhead and Diego Mastroeni, associate research professors at the ASU-Banner Neurodegenerative Disease Research Center ...

Wolfe Research lowered the firm’s price target on Moderna (MRNA) to $25 from $35 and keeps an Underperform rating on the shares. The firm ...

MRNA's competitive landscape, particularly against Pfizer, and higher forward P/S ratio suggest the stock is overvalued and ...

Pediatr Infect Dis J. 2005;24(12):1105-1106. Second, sensitive and specific methods now exist for serologic diagnosis of a primary CMV infection with the use of single or serial blood samples ...